Literature DB >> 30771435

CXCL11 promotes self-renewal and tumorigenicity of α2δ1+ liver tumor-initiating cells through CXCR3/ERK1/2 signaling.

Yuan Zhang1, Wei Zhao1, Sheng Li1, Mengzhu Lv1, Xiaodan Yang1, Meng Li1, Zhiqian Zhang2.   

Abstract

Tumor-initiating cells (TICs), which are responsible for sustaining tumor growth and recurrence, rely on several regulatory factors. However, the mechanism of inflammation-related molecules in the acquisition and maintenance of TIC properties in hepatocellular carcinoma (HCC) remains elusive. We previously demonstrated that the voltage-gated calcium channel α2δ1 subunit is a functional surface marker of HCC TICs. Here, we found that the expression of an inflammation-related molecule C-X-C motif chemokine 11 (CXCL11) was significantly upregulated in α2δ1+ HCC TICs and that CXCL11 induced the expression of stem cell-related genes, such as BMI1, NANOG, MDR1, ABCG2, and CACNA2D1. Furthermore, CXCL11 could promote the acquisition and maintenance of self-renewal, tumorigenic, and chemoresistance properties of α2δ1+ HCC TICs by activating the extracellular signal-regulated kinase (ERK1/2) through its affinity receptor CXCR3. Collectively, our results suggest that CXCL11 may positively regulate the stemness of α2δ1+ HCC TICs via ERK1/2 activation through an autocrine signaling pathway.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CXCL11; CXCR3; ERK1/2; Hepatocellular carcinoma; Tumor-initiating cell

Year:  2019        PMID: 30771435     DOI: 10.1016/j.canlet.2019.02.016

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

Review 1.  Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer.

Authors:  Jing Xu; Jing-Quan Li; Qi-Lei Chen; Elena A Shestakova; Vsevolod A Misyurin; Vadim S Pokrovsky; Elena M Tchevkina; Hu-Biao Chen; Hang Song; Jian-Ye Zhang
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

2.  The Highly Expressed IFIT1 in Nasopharyngeal Carcinoma Enhances Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.

Authors:  Xuan Wu; Liping Lin; Fengrui Zhou; Shaokang Yu; Minhua Chen; Shubin Wang
Journal:  Mol Biotechnol       Date:  2022-01-17       Impact factor: 2.860

Review 3.  The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.

Authors:  Nathan Reynders; Dayana Abboud; Alessandra Baragli; Muhammad Zaeem Noman; Bernard Rogister; Simone P Niclou; Nikolaus Heveker; Bassam Janji; Julien Hanson; Martyna Szpakowska; Andy Chevigné
Journal:  Cells       Date:  2019-06-18       Impact factor: 6.600

4.  miR-1298-5p Influences the Malignancy Phenotypes of Breast Cancer Cells by Inhibiting CXCL11.

Authors:  Jie Zhang; Dawei Hu
Journal:  Cancer Manag Res       Date:  2021-01-11       Impact factor: 3.989

5.  Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis.

Authors:  Gao Liu; Jian Sun; Zhang-Fu Yang; Cheng Zhou; Pei-Yun Zhou; Ruo-Yu Guan; Bao-Ye Sun; Zhu-Tao Wang; Jian Zhou; Jia Fan; Shuang-Jian Qiu; Yong Yi
Journal:  Cell Death Dis       Date:  2021-03-11       Impact factor: 8.469

6.  Role of chemokines in hepatocellular carcinoma (Review).

Authors:  Dongdong Xue; Ya Zheng; Junye Wen; Jingzhao Han; Hongfang Tuo; Yifan Liu; Yanhui Peng
Journal:  Oncol Rep       Date:  2020-12-22       Impact factor: 3.906

Review 7.  Calcium channelopathies and intellectual disability: a systematic review.

Authors:  Miriam Kessi; Baiyu Chen; Jing Peng; Fangling Yan; Lifen Yang; Fei Yin
Journal:  Orphanet J Rare Dis       Date:  2021-05-13       Impact factor: 4.123

Review 8.  CXCL11 Signaling in the Tumor Microenvironment.

Authors:  Qun Gao; Yi Zhang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential.

Authors:  Yu-Man Tsui; Lo-Kong Chan; Irene Oi-Lin Ng
Journal:  Br J Cancer       Date:  2020-03-31       Impact factor: 7.640

10.  Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance.

Authors:  Wei Zhao; Bo Ma; Zhihua Tian; Haibo Han; Jintian Tang; Bin Dong; Guo An; Baoshan Cao; Boqing Wang
Journal:  Br J Cancer       Date:  2021-01-21       Impact factor: 9.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.